Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merli

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|April 16, 2017
Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antiviralsHamid Hasson, Marco Merli, Emanuela Messina, et al.
The New Microbiologica|October 31, 2012
HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study)Hamid Hasson, Laura Galli, Giulia Gallotta, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosisMarco Merli, Laura Galli, Letizia Marinaro, et al.
Antibiotics (Basel, Switzerland)|August 29, 2024
Cefiderocol-Based Regimen for Acinetobacter NDM-1 OutbreakGiovanna Travi, Francesco Peracchi, Marco Merli, et al.
Journal of Viral Hepatitis|February 11, 2023
Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individualsRoberto Rossotti, Marco Merli, Chiara Baiguera, et al.
Medicine|October 30, 2015
Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/RibavirinSabrina Bagaglio, Caterina Uberti-Foppa, Clelia Di Serio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2020
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumabAndrea Lauterio, Mila Valsecchi, Sara Santambrogio, et al.
Sexually Transmitted Diseases|November 4, 2025
Patterns and correlates of initiation of long-acting injectable cabotegravir for pre-exposure prophylaxis: a case-control analysisRoberto Rossotti, Gabriele Cavazza, Enrico Caruso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2020
Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experienceGiovanna Travi, Roberto Rossotti, Marco Merli, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|April 16, 2017
Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antiviralsHamid Hasson, Marco Merli, Emanuela Messina, et al.
The New Microbiologica|October 31, 2012
HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study)Hamid Hasson, Laura Galli, Giulia Gallotta, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosisMarco Merli, Laura Galli, Letizia Marinaro, et al.
Antibiotics (Basel, Switzerland)|August 29, 2024
Cefiderocol-Based Regimen for Acinetobacter NDM-1 OutbreakGiovanna Travi, Francesco Peracchi, Marco Merli, et al.
Journal of Viral Hepatitis|February 11, 2023
Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individualsRoberto Rossotti, Marco Merli, Chiara Baiguera, et al.
Medicine|October 30, 2015
Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/RibavirinSabrina Bagaglio, Caterina Uberti-Foppa, Clelia Di Serio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2020
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumabAndrea Lauterio, Mila Valsecchi, Sara Santambrogio, et al.
Sexually Transmitted Diseases|November 4, 2025
Patterns and correlates of initiation of long-acting injectable cabotegravir for pre-exposure prophylaxis: a case-control analysisRoberto Rossotti, Gabriele Cavazza, Enrico Caruso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2020
Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experienceGiovanna Travi, Roberto Rossotti, Marco Merli, et al.
Pageof 9